Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAgxmbO2xXrnagG8Vn_g96GE4sXNQWgfx0nUt2vFQAm7Q#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "gazyva obinutuzumab is a cd2 directed cytolytic antibody and is indicated in combination with chlorambucil for the treatment of patients with previously untreated chronic lymphocytic leukemia 1 14 in combination with bendamustine followed by gazyva monotherapy for the treatment of patients with follicular lymphoma who relapsed after or are refractory to a rituximab containing regimen 1 14 in combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission for the treatment of adult patients with previously untreated stage ii bulky iii or iv follicular lymphoma 1 14 gazyva in combination with chlorambucil is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia see clinical studies 14 1 gazyva in combination with bendamustine followed by gazyva monotherapy is indicated for the treatment of patients with follicular lymphoma who relapsed after or are refractory to a rituximab containing regimen see clinical studies 14 2 gazyva in combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission is indicated for the treatment of adult patients with previously untreated stage ii bulky iii or iv follicular lymphoma see clinical studies 14 2" assertion.
- association subject drugbank:DB08935 assertion.
- association predicate treats assertion.
- association object DOID_1040 assertion.
- association relation TreatmentIndication assertion.
- DOID_1040 category Disease assertion.
- drugbank:DB08935 category Drug assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.